SELLAS Life Sciences (SLS) EPS (Basic) (2010 - 2026)
SELLAS Life Sciences (SLS) posted quarterly EPS (Basic) of -$0.09 for Q1 2026, down 22.29% year-over-year from -$0.11 in Q1 2025, and down 13.91% quarter-over-quarter from -$0.08 in Q4 2025.
SELLAS Life Sciences (SLS) EPS (Basic) (2010 - 2026) Analysis & Trends
SELLAS Life Sciences (SLS) has reported EPS (Basic) for 17 consecutive years, with -$0.09 the latest figure, recorded in Q1 2026.
- In Q1 2026, EPS (Basic) fell 22.29% year-over-year to -$0.09; the TTM figure through Mar 2026 stood at -$0.23 (up 29.09% YoY), while the FY2025 annual figure was -$0.47, up 45.23% from the prior year.
- EPS (Basic) declined to -$0.09 in Q1 2026 per SLS's latest filing, from -$0.08 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.07 in Q3 2025 and bottomed at -$1.06 in Q1 2022.
- Historically, EPS (Basic) has averaged -$0.28 across 5 years, with a median of -$0.22 in 2024.
- Annual changes were most pronounced in 2022 — EPS (Basic) plunged 555.63% — and 2024, when it soared 67.38%.
- SELLAS Life Sciences' EPS (Basic) stood at -$0.5 in 2022, then soared by 40.08% to -$0.3 in 2023, then surged by 61.52% to -$0.11 in 2024, then soared by 33.19% to -$0.08 in 2025, then declined by 13.91% to -$0.09 in 2026.
- Business Quant data shows SLS's EPS (Basic) at -$0.09 in Q1 2026, -$0.08 in Q4 2025, and -$0.07 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | SELLAS Life Sciences | 2.32 Bn | 2.18 Bn | - | -0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.23 |
| Mar 31, 2026 | -0.09 |
| Dec 31, 2025 | -0.08 |
| Sep 30, 2025 | -0.07 |
| Jun 30, 2025 | -0.09 |
| Mar 31, 2025 | -0.07 |
| Dec 31, 2024 | -0.11 |
| Sep 30, 2024 | -0.11 |
| Jun 30, 2024 | -0.13 |
| Mar 31, 2024 | -0.22 |
| Dec 31, 2023 | -0.30 |
| Sep 30, 2023 | -0.33 |
| Jun 30, 2023 | -0.32 |
| Mar 31, 2023 | -0.48 |
| Dec 31, 2022 | -0.50 |
| Sep 30, 2022 | -0.35 |
| Jun 30, 2022 | -0.43 |
| Mar 31, 2022 | -1.06 |
| Dec 31, 2021 | -0.43 |
| Sep 30, 2021 | -0.45 |